Daniel Spratt
Daniel Spratt
University Hospitals Seidman Cancer Center/CWRU
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ...
Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
Androgen Receptor Signaling Regulates DNA Repair in Prostate CancersAndrogen Receptor Signaling Regulates DNA Repair
WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ...
Cancer discovery 3 (11), 1245-1253, 2013
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
BW Cox, DE Spratt, M Lovelock, MH Bilsky, E Lis, S Ryu, J Sheehan, ...
International Journal of Radiation Oncology* Biology* Physics 83 (5), e597-e605, 2012
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
ZS Zumsteg, DE Spratt, I Pei, Z Zhang, Y Yamada, M Kollmeier, ...
European urology 64 (6), 895-902, 2013
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
A Bosch, Z Li, A Bergamaschi, H Ellis, E Toska, A Prat, JJ Tao, DE Spratt, ...
Science translational medicine 7 (283), 283ra51-283ra51, 2015
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
DE Spratt, X Pei, J Yamada, MA Kollmeier, B Cox, MJ Zelefsky
International Journal of Radiation Oncology* Biology* Physics 85 (3), 686-692, 2013
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
R Morrison, SM Schleicher, Y Sun, KJ Niermann, S Kim, DE Spratt, ...
Journal of oncology 2011, 2011
Association of black race with prostate cancer–specific and other-cause mortality
RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ...
JAMA oncology 5 (7), 975-983, 2019
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
Racial/ethnic disparities in genomic sequencing
DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ...
JAMA oncology 2 (8), 1070-1074, 2016
Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ...
International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019
Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality
DE Spratt, C Zhang, ZS Zumsteg, X Pei, Z Zhang, MJ Zelefsky
European urology 63 (4), 709-716, 2013
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
DE Spratt, WH Beeler, FY de Moraes, LD Rhines, JJ Gemmete, ...
The Lancet Oncology 18 (12), e720-e730, 2017
Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.
DE Spratt, K Yousefi, S Deheshi, AE Ross, RB Den, EM Schaeffer, ...
American Society of Clinical Oncology 35 (18), 1991, 2017
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors
RJ Passarella, DE Spratt, AE Van Der Ende, JG Phillips, H Wu, ...
Cancer research 70 (11), 4550-4559, 2010
Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer
DE Spratt, J Zhang, M Santiago-Jiménez, RT Dess, JW Davis, RB Den, ...
Journal of Clinical Oncology 36 (6), 581, 2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20